04/09/2024
First Participant Dosed in Phase 1 Clinical Trial of Gamma-PN in Older Adults
Adelaide, Australia, 5th September 2024 – GPN Vaccines Ltd is pleased to announce that the first participant has…
Adelaide, Australia, 5th September 2024 – GPN Vaccines Ltd is pleased to announce that the first participant has…
Adelaide, Australia, 21st August 2024 GPN Vaccines is pleased to announce it has received ethics approval to commence…
Adelaide, Australia, 6th June 2024 – GPN Vaccines is pleased to announce the closing of its oversubscribed Series…
Adelaide, Australia – 7th May 2024 GPN Vaccines Ltd is pleased to announce the successful award of $936,000…
Adelaide, Australia GPN Vaccines is pleased to announce that Dr Erin Brazel has been awarded a Junior Fellowship…
Adelaide, Australia GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to prevent life-threatening pneumonia, bacteraemia…